New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Phio Pharmaceuticals Corp.
PHIO
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Biotechnology

Next Earning date - 14 Nov 2024

2M

Biotechnology

Next Earning date - 14 Nov 2024

2.68USD
Shape0.10 ( 3.88%)
favorite-chart

Relative Strenght

8
favorite-chart

Volume Buzz

-67%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

86%

Quote Panel

Shape
Updated October 12, 2024
1W -7.27 % 1M -18.54 % 3M -42.61 % 1Y -80.01 %

Key Metrics

Shape
  • Market Cap

    2.31M


  • Shares Outstanding

    860721


  • Share in Float

    828553


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    2.68


  • Average Volume

    58376


  • Beta

    1.452


  • Range

    2.4-18.81


  • Industry

    Biotechnology


  • Website

    https://www.phiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

73.16x

P/S Ratio

0.34x

P/B Ratio

0.0

Debt/Equity

-28916.7%

Net Margin

$-16.1

EPS

How PHIO compares to sector?

P/E Ratio

Relative Strength

Shape

PHIO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$75M

ShapeNaN%

2025-Revenue

$34.02

Shape1040%

2025-EPS

$45M

Shape2452%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-28.09
vs -30.26

Q4.22

arrow
arrow

N/A

-2.40
vs -27.01

Q1.23

arrow
arrow

N/A

-28.35
vs -20.53

Q2.23

arrow
arrow

N/A

-13.23
vs -20.53

Q3.23

arrow
arrow

N/A

-10.26
vs -28.09

Q4.23

arrow
arrow

N/A

-0.85
vs -2.40

Q1.24

arrow
arrow

N/A

-4.23
vs -28.35

Q2.24

arrow
arrow

N/A

-3.62
vs -13.23

Q3.24

arrow
arrow

N/A

-4.14
vs -10.26

Q4.24

arrow
arrow

N/A

-3.60
vs -0.85

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

30K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-26%

-0.26
vs -0.15

Q4.22

arrow
arrow

-24%

-0.24
vs -0.26

Q1.23

arrow
arrow

-49%

-0.49
vs -0.24

Q2.23

arrow
arrow

-26%

-0.26
vs -0.49

Q3.23

arrow
arrow

-39%

-0.39
vs -0.26

Q4.23

arrow
arrow

-25%

-0.25
vs -0.39

Q1.24

arrow
arrow

-38%

-0.38
vs -0.25

Q2.24

arrow
arrow

-49%

-0.49
vs -0.38

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

16

16
vs 9

78%

Q2.21

arrow
arrow

20

20
vs 16

25%

Q3.21

arrow
arrow

18

18
vs 20

-10%

Q4.21

arrow
arrow

18

18
vs 18

NA

Q1.22

arrow
arrow

13

13
vs 18

-28%

Q2.22

arrow
arrow

10

10
vs 13

-23%

Q3.22

arrow
arrow

13

13
vs 10

30%

Q4.22

arrow
arrow

11

11
vs 13

-15%

Earnings Growth

Latest News